PATENT CLAIM ANALYSIS

Application Number: 15917151
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "450000"]

Abstract:
An exosomal composition is provided that comprises a therapeutic agent encapsulated by an exosome. The therapeutic agent can be a phytochemical agent, a chemotherapeutic agent, or a Stat3 inhibitor. Pharmaceutical compositions comprising the exosomal compositions are also provided. Methods for treating an inflammatory disease or a cancer are further provided and include administering an effective amount of an exosomal composition to a subject in need thereof to thereby treat the inflammatory disorder or the cancer.

Claim (Index 5):
The exosomal composition of  claim 4 , wherein the Stat3 inhibitor is JSI-124.

Metadata:
- Claim Count in Document: 73.0
- Percentile: 90.0
- Lexical Diversity: 1.58824
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14770634', '15910322', '14825957', '13429601', '14009311']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7568972962108268
- 35 USC 102 Novelty (BERT): 0.5425937780398243
- Combined Prediction Score: 0.7354669443937265
- Mean Citation Score: 342.03769
- Max Citation Score: 414.47324
- Similarity Product: 232.79894093806743

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test